On the heels of #AHA25, EchoPrime is published in @Nature!
EchoPrime has the strong performance in a wide range of echo interpretation tasks and is validated across 5 international hospitals.
Led by @milos_ai and @bryandhe.
1/n
We’re thrilled to announce the 2025 Microbiome SMRT Grant winners! 🎉 Four researchers from around the globe will use HiFi sequencing to push the boundaries of metagenomics.
See the awardees and their projects: https://t.co/ZEq0tx2UnA
#PacBio#Microbiome#Genomics#SMRTGrant
Honored to be named Program Director for GI Medical Oncology @MGHCancerCenter , focused on CRC, Anal & NET. Grateful to collaborate with incredible colleagues like @KlempnerSam leading UGI and Harsh Singh joining us for HBP. excited to build on innovation & equity in cancer care.
We are excited to work with @StanfordDeptMed, @SmidtHeart, @mghliver, and @KPDOR with the support of @American_Heart to refine and prospectively evaluate AI opportunistic screening approaches for Cardiovascular-Kidney-Metabolic Health!
Chronic Liver and Kidney Disease is common in cardiovascular patients, and cardiovascular disease is the leading cause of death in patients with CKD and CLD. Unfortunately, CKD and CLD is often asymptomatic and most patients do not know they have the diseases at the earliest stage.
We previously published in @NEJM_AI and @eBioMedicine that AI enhanced echocardiography can identify CKD and CLD disease, and such opportunistic screening AI can identify cases before patients or their doctors know about their diseases.
Working with @AndrewPAmbrosy@ankeetbhatt@LongNguyen07@traceyg_md@emilyswlau@ATSandhu and other collaborators not on X, we are conducting a prospective multi-center clinical trial validating AI enhanced echocardiography for opportunistic screening.
Thank you to the @American_Heart for the strong focus on improving the heart health of all Americans and expanding access to care for patients with liver and kidney disease!
Read the #GUTOnline#GUTInTheNews#GUTPressRelease paper by @wenjie_ma2 et al entitled
"Lifestyle factors, genetic susceptibility and risk of incident diverticulitis: an integrated analysis of four prospective cohort studies and electronic health records-linked biobank" via
https://t.co/rDAuKRbTuE
@MGH_CTEU@HarvardChanSPH@AndyChanMD #Diverticulitis
⚡🦠I'm excited to share that our latest work on the gut microbiome and metabolic dysfunction-associated steatotic liver disease (MASLD) is now published in @NatMetabolism, with @hutlab & @LongNguyen07!
Check out the paper here:
🔗https://t.co/dEJytGEQHE
👇Tweetorial
Our News & Views piece is out at Nature Metabolism. We discussed the role of gut virome in MASLD, particularly the importance of virome
https://t.co/QvcwohdTB4
The new version of MetaPhlAn (v4.2.2) released!
📌taxonomic profiling of long-read metagenomes for the first time
📌new version of the MetaPhlAn db (vJan25_202503) containing >21k new SGBs
Try it out & @hutlab and we are looking forward to your feedback!
https://t.co/Y1JXrKS4SG
Explore gut viral ecology in IBD with @MGH_CTEU & @shen_jiaxian on May 6 at 4 PM (Location 27, SDCC).
We’re proud to celebrate Jiaxian’s recognition with a Fellow Abstract Award—thank you #DDW2025 & @AmerGastroAssn for supporting early-career researchers!
Can gut viruses help us determine colorectal cancer risk in Lynch Syndrome patients? @nanakoxxxxxxx's poster explores the viral microbiome as a potential biomarker for early cancer detection in this high-risk population.
@LongNguyen07#Microbiome#LynchSyndrome#CRC#DDW2025